You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cervical squamous cell carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Cervical Cancer Screening by Self-sampling HPV Test

Recruiting
  • Human Papillomavirus Infection
  • +16 more
    • Beijing, Beijing, China
    • +5 more
    Jan 12, 2023

    Cervical Squamous Cell Carcinoma In Situ, Vulvar High Grade Squamous Intraepithelial Lesion Trial in Los Angeles, Oklahoma City

    Recruiting
    • Cervical Squamous Cell Carcinoma In Situ
    • Vulvar High Grade Squamous Intraepithelial Lesion
    • Los Angeles, California
    • +1 more
    Aug 19, 2022

    Human Papilloma Virus Circulating Tumor DNA in Cervical Cancer

    Recruiting
    • Cervical Adenosquamous Carcinoma
    • +26 more
    • Biospecimen Collection
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 4, 2023

    Cervical Squamous Cell Carcinoma Trial in Beijing (Nimotuzumab, EBRT combined with brachytherapy)

    Not yet recruiting
    • Cervical Squamous Cell Carcinoma
    • Beijing, Beijing, China
      Peking University 3rd Hospital
    Jul 21, 2021

    Cervical Cancer, Throat Cancer, Oropharynx Cancer Trial in New Brunswick (E7 TCR-T cells)

    Not yet recruiting
    • Cervical Cancer
    • +20 more
    • E7 TCR-T cells
    • New Brunswick, New Jersey
    • +1 more
    Jan 18, 2023

    Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in

    Recruiting
    • Cervical Adenocarcinoma
    • +11 more
    • Media Intervention
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 15, 2022

    HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, HPV-Related Malignancy Trial in New Brunswick (Conditioning, E7 TCR-T

    Not yet recruiting
    • HPV-Associated Cervical Carcinoma
    • +16 more
    • Conditioning, E7 TCR-T cells, and aldesleukin
    • New Brunswick, New Jersey
      Rutgers Cancer Institute of New Jersey
    Jan 17, 2023

    Head Neck Cancer, Cervical Cancer, Non-small Cell Carcinoma Trial in Scottsdale, Chapel Hill (TSC-204-A0201, TSC-204-C0702,

    Not yet recruiting
    • Head and Neck Cancer
    • +20 more
    • TSC-204-A0201
    • +4 more
    • Scottsdale, Arizona
    • +1 more
    Aug 3, 2023

    Cervical Cancer, Head and Neck Squamous Cell Carcinoma, NSCLC Trial in Boston, Saint Louis (ITIL-168)

    Withdrawn
    • Cervical Cancer
    • +2 more
    • ITIL-168
    • (no location specified)
    Dec 16, 2022

    Carcinoma, Squamous Cell of Head and Neck, HPV Positive Oropharyngeal Squamous Cell Carcinoma, Hypopharyngeal Cancer Trial in

    Completed
    • Carcinoma, Squamous Cell of Head and Neck
    • +5 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 24, 2022

    Cervical Intraepithelial Neoplasia Grade 2/3, Cervical Squamous Cell Carcinoma In Situ, Cervical Squamous Intraepithelial

    Active, not recruiting
    Has Results
    • Cervical Intraepithelial Neoplasia Grade 2/3
    • +3 more
    • Chapel Hill, North Carolina
      UNC Lineberger Comprehensive Cancer Center
    Jan 28, 2022

    Cervical Intraepithelial Neoplasia, Cervical Squamous Cell Carcinoma In Situ, Cervical Squamous Intraepithelial Neoplasia 2

    Recruiting
    • Cervical Intraepithelial Neoplasia
    • +2 more
    • Pembrolizumab
    • Los Angeles, California
      University of California at Los Angeles / Jonsson Comprehensive
    Jan 20, 2022

    Non Small Cell Lung Cancer, Hepatocellular Carcinoma, Melanoma Trial in United States (MT-8421, Nivolumab)

    Recruiting
    • Non Small Cell Lung Cancer
    • +10 more
    • Los Angeles, California
    • +4 more
    Sep 5, 2023

    Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,

    Not yet recruiting
    • Diffuse Astrocytoma, IDH-Mutant
    • +20 more
    • NEO212 Oral Capsule
    • +8 more
    • (no location specified)
    Sep 18, 2023

    Hybrid PET/MR in the Therapy of Cervical Cancer

    Completed
    • Cervix Carcinoma
    • +2 more
    • FDG PET/MR
    • Chapel Hill, North Carolina
      University of North Carolina-Chapel Hill
    Dec 2, 2021

    Cervical Cancer, Head and Neck Squamous Cell Carcinoma, Carcinoma of Vagina Trial in Shanghai (HRYZ-T101 Injection, Fludarabine

    Not yet recruiting
    • Cervical Cancer
    • +5 more
    • HRYZ-T101 Injection
    • Fludarabine + Cyclophosphamide
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jul 17, 2023

    MRI and PET Imaging in Predicting Treatment Response in Stage

    Active, not recruiting
    • Cervical Adenocarcinoma
    • +12 more
    • Computed Tomography
    • +5 more
    • Miami, Florida
    • +5 more
    Oct 4, 2022

    Cervical Cancer, Head and Neck Squamous Cell Carcinoma, Oropharyngeal Cancer Trial in Shanghai (Fludarabine + Cyclophosphamide,

    Not yet recruiting
    • Cervical Cancer
    • +6 more
    • Fludarabine + Cyclophosphamide
    • HRYZ-T101 TCR-T Cell
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Mar 27, 2023

    Carcinoma, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma Trial (XNW5004, Pembrolizumab 25 mg/mL Solution for

    Not yet recruiting
    • Carcinoma
    • +7 more
    • XNW5004
    • Pembrolizumab 25 mg/mL Solution for Injection
    • (no location specified)
    Aug 31, 2023

    Squamous Cell Lung Cancer, Vulvar Cancer, Penile Cancer Trial in France (pembrolizumab; vorinostat)

    Active, not recruiting
    • Squamous Cell Lung Cancer
    • +5 more
    • pembrolizumab; vorinostat
    • Angers, France
    • +13 more
    Jan 4, 2023

    Clinical Evaluation of Detection of High Risk HPV in Urine

    Recruiting
    • Human Papillomavirus Infection
    • +17 more
      • Beijing, Beijing, China
      • +2 more
      Jan 21, 2022

      Advanced Cancer, Advanced Malignancies, Bladder Cancer Trial (AB598, Zimberelimab, Carboplatin)

      Not yet recruiting
      • Advanced Cancer
      • +11 more
      • (no location specified)
      May 26, 2023

      Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Cervical Cancer Trial run by the (NEO-201 in combination

      Recruiting
      • Non Small Cell Lung Cancer
      • +3 more
      • NEO-201 in combination with pembrolizumab
      • Bethesda, Maryland
        National Cancer Institute
      Apr 1, 2022

      Will Permit Sites to Proactively Assess TAA, HLA and HPV-16

      Terminated
      • Head and Neck Cancer
      • +7 more
      • Tumor Profiling
      • Scottsdale, Arizona
      • +2 more
      Dec 2, 2022

      Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in

      Withdrawn
      • Cervical Adenocarcinoma
      • +6 more
      • Cape Town, South Africa
      • +2 more
      Jun 14, 2022